BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 34689344)

  • 41. PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients.
    Peng G; Li S; Wu W; Tan X; Chen Y; Chen Z
    Mol Immunol; 2008 Feb; 45(4):963-70. PubMed ID: 17868872
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Blockade of CCR4 breaks immune tolerance in chronic hepatitis B patients by modulating regulatory pathways.
    Khanam A; Ghosh A; Chua JV; Kottilil S
    J Transl Med; 2023 Apr; 21(1):271. PubMed ID: 37081509
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis B e-antigen persistency is associated with the properties of HBV-specific CD8 T cells in CHB patients.
    Peng G; Luo B; Li J; Zhao D; Wu W; Chen F; Chen Z
    J Clin Immunol; 2011 Apr; 31(2):195-204. PubMed ID: 21120686
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interleukin 21 Reinvigorates the Antiviral Activity of Hepatitis B Virus (HBV)-Specific CD8+ T Cells in Chronic HBV Infection.
    Tang L; Chen C; Gao X; Zhang W; Yan X; Zhou Y; Guo L; Zheng X; Wang W; Yang F; Liu G; Sun J; Hou J; Li Y
    J Infect Dis; 2019 Feb; 219(5):750-759. PubMed ID: 30260401
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Alterations of IFN-γ and IL-4 of peripheral blood T cells in patients with chronic HBV infection].
    Li M; Sun X; Zhou Z; Zhang X; Jin S; Gao Y; Gao Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):240-4. PubMed ID: 26927386
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The expression of programmed death-1 in circulating CD4+ and CD8+ T cells during hepatitis B virus infection progression and its correlation with clinical baseline characteristics.
    Xu P; Chen YJ; Chen H; Zhu XY; Song HF; Cao LJ; Wang XF
    Gut Liver; 2014 Mar; 8(2):186-95. PubMed ID: 24672661
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice.
    Martin P; Dubois C; Jacquier E; Dion S; Mancini-Bourgine M; Godon O; Kratzer R; Lelu-Santolaria K; Evlachev A; Meritet JF; Schlesinger Y; Villeval D; Strub JM; Van Dorsselaer A; Marchand JB; Geist M; Brandely R; Findeli A; Boukhebza H; Menguy T; Silvestre N; Michel ML; Inchauspé G
    Gut; 2015 Dec; 64(12):1961-71. PubMed ID: 25429051
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human CXCR5
    Hofland T; Martens AWJ; van Bruggen JAC; de Boer R; Schetters S; Remmerswaal EBM; Bemelman FJ; Levin MD; Bins AD; Eldering E; Kater AP; Tonino SH
    Eur J Immunol; 2021 Mar; 51(3):703-713. PubMed ID: 33098668
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Baseline HBsAg levels associated with HBsAg loss in HBeAg-negative chronic hepatitis B infection with persistently normal alanine aminotransferase.
    Chen L; Shi J; Lu Z; Ye Y; Zhou X; Tan Y
    Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):310-316. PubMed ID: 30528063
    [TBL] [Abstract][Full Text] [Related]  

  • 50. OX40 stimulation and PD-L1 blockade synergistically augment HBV-specific CD4 T cells in patients with HBeAg-negative infection.
    Jacobi FJ; Wild K; Smits M; Zoldan K; Csernalabics B; Flecken T; Lang J; Ehrenmann P; Emmerich F; Hofmann M; Thimme R; Neumann-Haefelin C; Boettler T
    J Hepatol; 2019 Jun; 70(6):1103-1113. PubMed ID: 30826436
    [TBL] [Abstract][Full Text] [Related]  

  • 51. IL-35 expression in peripheral blood CD4(+) T cells from chronic hepatitis B virus-infected patients directly correlates with virus load.
    Zhou Y; Zhang H; Li Y
    Cytokine; 2015 May; 73(1):169-75. PubMed ID: 25752977
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CD8
    Nandi M; Pal S; Ghosh S; Chakraborty BC; Dey D; Baidya A; Shil A; Chattopadhyaya S; Banerjee S; Santra A; Chowdhury A; Datta S
    Clin Sci (Lond); 2019 Sep; 133(17):1917-1934. PubMed ID: 31477625
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Detection of peripheral follicular helper T cells in rheumatoid arthritis].
    An LM; Li J; Ji LL; Li GT; Zhang ZL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):951-957. PubMed ID: 27987496
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IL-33 Enhances Humoral Immunity Against Chronic HBV Infection Through Activating CD4(+)CXCR5(+) TFH Cells.
    Zhao PW; Shi X; Li C; Ayana DA; Niu JQ; Feng JY; Wang J; Jiang YF
    J Interferon Cytokine Res; 2015 Jun; 35(6):454-63. PubMed ID: 25714983
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B.
    Rinker F; Zimmer CL; Höner Zu Siederdissen C; Manns MP; Kraft ARM; Wedemeyer H; Björkström NK; Cornberg M
    J Hepatol; 2018 Sep; 69(3):584-593. PubMed ID: 29758333
    [TBL] [Abstract][Full Text] [Related]  

  • 56. TNF-α/IFN-γ profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection.
    Wang H; Luo H; Wan X; Fu X; Mao Q; Xiang X; Zhou Y; He W; Zhang J; Guo Y; Tan W; Deng G
    J Hepatol; 2020 Jan; 72(1):45-56. PubMed ID: 31499130
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD4+ CXCR5+ T cells in chronic HCV infection produce less IL-21, yet are efficient at supporting B cell responses.
    Spaan M; Kreefft K; de Graav GN; Brouwer WP; de Knegt RJ; ten Kate FJ; Baan CC; Vanwolleghem T; Janssen HL; Boonstra A
    J Hepatol; 2015 Feb; 62(2):303-10. PubMed ID: 25281860
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Circulating chemokine (C-X-C Motif) receptor 5(+) CD4(+) T cells benefit hepatitis B e antigen seroconversion through IL-21 in patients with chronic hepatitis B virus infection.
    Li Y; Ma S; Tang L; Li Y; Wang W; Huang X; Lai Q; Zhang M; Sun J; Li CK; Abbott WG; Naoumov NV; Zhang Y; Hou J
    Hepatology; 2013 Oct; 58(4):1277-86. PubMed ID: 23703545
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dynamic decrease in PD-1 expression correlates with HBV-specific memory CD8 T-cell development in acute self-limited hepatitis B patients.
    Zhang Z; Jin B; Zhang JY; Xu B; Wang H; Shi M; Wherry EJ; Lau GK; Wang FS
    J Hepatol; 2009 Jun; 50(6):1163-73. PubMed ID: 19395117
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Natural course of chronic hepatitis B is characterized by changing patterns of programmed death type-1 of CD8-positive T cells.
    Liang XS; Zhou Y; Li CZ; Wan MB
    World J Gastroenterol; 2010 Feb; 16(5):618-24. PubMed ID: 20128032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.